Lesion revascularisation subsequent to femoropopliteal spot stenting using the multi-LOC stent delivery system
Background/Aim: Restenosis and stent fractures are well-characterised treatment failures following femoropopliteal (FP) stent-based interventions. We aimed to determine patterns of restenosis and fracture rates following focal stenting of FP arteries. Patients and Methods: This retrospective study i...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
January-February 2020
|
| In: |
In vivo
Year: 2020, Volume: 34, Issue: 1, Pages: 433-439 |
| ISSN: | 1791-7549 |
| DOI: | 10.21873/invivo.11792 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.21873/invivo.11792 Verlag, kostenfrei, Volltext: http://iv.iiarjournals.org/content/34/1/433 |
| Author Notes: | Martin Sigl, Klaus Amendt, Matthias Waliszewski and Nils Rathmann |
| Summary: | Background/Aim: Restenosis and stent fractures are well-characterised treatment failures following femoropopliteal (FP) stent-based interventions. We aimed to determine patterns of restenosis and fracture rates following focal stenting of FP arteries. Patients and Methods: This retrospective study investigated angiographic patterns of restenosis and the occurrence of stent fractures following focal FP stenting with the multiple stent delivery system VascuFlex® Multi-LOC. Results: We identified 10 patients with 10 (of 129) FP lesions (mean length 11.7±4.6 cm) and a total of 51 (of 646) Multi-LOC stents that underwent clinically driven target lesion revascularizations (TLR) after 11.5±9.2 months, due to symptomatic recurrence of stenosis. None of the Multi-LOC stents had fractured. No isolated in-stent restenosis (>50%) was observed. Median diameter lumen loss was significantly more pronounced at the inter-stent segments (27.0%) compared to in-stent segments (7.8%, p=0.023). Conclusion: No evidence of fracture or susceptibility to stent-related restenosis using Multi-LOC stents was observed. Focal FP stenting may be more effective when combined with strategies known to reduce restenosis in non-stented artery segments. |
|---|---|
| Item Description: | Gesehen am 10.03.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1791-7549 |
| DOI: | 10.21873/invivo.11792 |